Kirkland & Ellis LLP

Graham Robinson is an M&A partner in the Boston office of Kirkland & Ellis LLP. Graham’s practice focuses on transactions involving the acquisitions of public companies, specifically within the biopharmaceutical industry. He is ranked first by deal value and number of deals among U.S. attorneys for public biotechnology M&A transactions since January 2016, according to Deal Point Data. Graham also has extensive experience within the shareholder activism space. He has helped companies prepare for and respond to unsolicited acquisition proposals, as well as dealing with activist investors. He provides counsel to boards of directors and special committees on corporate governance matters and internal investigations.

Graham has been recognized in the most recent rankings of Chambers Global, Chambers USA and The Best Lawyers in America, which named him its 2023 Boston Mergers & Acquisitions Law Lawyer of the Year. He was also named a 2024 Law360 MVP in the Life Sciences category. He has also been named one of MergerLinks’ Top Healthcare Lawyers in North America and Top Advisor Lawyers in North America.